Cell line modeling for systems medicine in cancers (Review)

Abstract excerpt

Unexpected drug efficacy or resistance is poorly understood in cancers because of the lack of systematic analyses of drug response profiles in cancer tissues of various genotypic backgrounds. The recent development of high‑throughput technologies has allowed massive screening of chemicals and drugs against panels of heterogeneous cancer cell lines. In parallel, multi‑level omics datasets, including genome‑wide...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer Genomics and Diagnostics
• Share to Gene expression and cancer classification
• Share to Pancreatic and Hepatic Oncology Research